Editas Medicine, Inc.
11 Hurley Street
Cambridge, MA 02141
March 30, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Editas Medicine, Inc.
Registration Statement on Form S-3
File No. 333-216528
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Editas Medicine, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-216528), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. eastern time on April 3, 2017, or as soon thereafter as practicable.